The global Dupuytren’s contracture market is expected to reach USD 5.5 billion by 2023, and the market is projected to grow at a CAGR of ~ 4.4 % during the forecast period 2017-2023.
- Agency -.
The Dupuytren’s Contracture Market report explores Information Types (Type I, Type II, Type III) By Diagnosis (Physical Examination, X-Ray, others) By Surgery (Needle Aponeurotomy (NA), others), Drug (Steroids, Collagenase Injection, others) By Therapy, and By End User - Global Forecast till 2023 . Dupuytren's contracture is a condition in which there is difficulty in articulating fingers due to formation of tissue knots under the skin.
In severe conditions, the fingers become permanently bent in a flexed position. Dupuytren's contracture is typically not painful and generally affects the ring finger followed by the little and middle fingers.
- Agency -.
Get Sample PDF Illustration @ www.marketresearchfuture.com/sample_request/4401 .
The exact causes of Dupuytren's contracture are unknown; however, the risk factors include alcoholism, smoking, thyroid problems, liver disease, diabetes, previous hand trauma, epilepsy, family history etc. Dupuytren's contracture has a higher rate in males over the age of 50.
There is also a genetic propensity with Caucasians being affected more while it is rare among Asians and Africans. Dupuytren's contracture has a regress rate of approximately 10% of patients.
The less severe forms of the disease are treated with steroid treatment and physiotherapy while surgery is usually performed when the metacarpophalangeal joint contracture exceeds 40 degrees or when the proximal interphalangeal joint contracture exceeds 20 degrees.
The annual incidence proportion was estimated at about 3 cases per 10,000 adults. The occurrence rate of this condition in the United States is about 5% of people, while Scandinavian nations have a higher rate of about 30% of men over 60 years old having the condition.
The market drivers for Dupuytren’s contracture market are, increase in risk factors rising incomes, growing screening, increasing geriatric population etc. The market restraints are cost of Dupuytren’s contracture surgery, complications and risk of the surgery, invasive nature of treatment, and regression of the disease even after treatment etc.
On the basis of diagnosis, the market is segmented into physical exam, imaging tests, and others. Imaging test is sub-segmented into ultrasound, Magnetic Resonance Imaging (MRI) scans, and others.
On the basis of treatments, the market has been segmented into medications, therapy, surgical repair, and others. Medication sub-segmented into pain relievers, corticosteroids, Platelet-Rich Plasma (PRP), and others.
Therapy is further sub-segmented into hot and cold therapy, physical therapy, occupational therapy, and others.
Key Players in the Global Dupuytren’s contracture Market: Bristol-Meyers Squibb Co., Fresenius Kabi AG, Merck Sharp & Dohme Corp., Pfizer Inc., West-Ward Pharmaceuticals, Spear Pharmacueticals, Actiza Pharmaceutical Private Limited, Nantong Jinghua Pharmaceutical Co., Ltd., Endo International plc, and others.
Regional Analysis: Europe accounted for a significant market share owing to extensive use of medications and high expenditure on the health care. Additionally, the greater prevalence of Dupuytren’s contracture in Europe drives the Dupuytren’s contracture market.
Also, concentration of major research companies in the developed countries of this region is adding fuel to the market growth. The highly developed healthcare system of the Scandinavian countries coupled with high expenditure on healthcare, cruises the sale of Dupuytren’s contracture treatment.
Europe is led by countries such as Germany and France with Norway, expected to be the fastest growing market.
Access report @ www.marketresearchfuture.com/check-discount/4401 .
US is the second largest market in the world due to high income and healthcare penetration. The presence of large healthcare players in the US benefits the market coupled with the high public expenditure on healthcare which comes to be approximately 16 % of the GDP.
Asia Pacific region is expected to grow at a slower rate with China and India are likely to lead this market due to fast growing healthcare sector during the forecast period. The lower prevalence of Dupuytren’s contracture in the Asian populations acts as a drag on the market.
Gulf nations such as Saudi Arabia and the UAE are estimated to drive the Middle East & African market. The development of large hospitals such as the King Fahd hospital in Riyadh is driving the market.
The African region is expected to witness a moderate growth owing to poor economic and political conditions and poor healthcare development. Also, the lower prevalence of Dupuytren’s contracture in the Asian populations acts as a drag on the market.
Category: Market Research Publishers and RetailersCompany profile: At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
For more information: